Global Blood Therapeutics said to draw takeover interest, reveals Bloomberg
Global Blood Therapeutics, a US-listed biopharmaceutical company, is a business that has been on Betaville's radar for quite a few years amid vague rumours.
Now, though, arch rivals at Bloomberg are reporting that the company - which makes drugs for sickle cell disease - is working with advisers amid takeover interest from larger rivals.
Below is a link to the Bloomberg scoop, which has sent shares in Global Blood Therapeutics up 30pc overnight.....
Register for free to see rest of this article and all public articles from BetavilleLogin / Register